GastroPanel® ELISA Panel

Helsinki, Finland

At Biohit, our mission is clear: Innovating for health. Biohit Oyj is a globally operating Finnish biotechnology company that develops diagnostic and other health products. Biohit is headquartered in Helsinki and has subsidiaries in Italy and the United Kingdom. Biohit’s Series B shares (BIOBV) have been listed on NASDAQ OMX Helsinki since 1999, in the Small Cap / Healthcare segment. The company was established in 1988. We aim to make healthcare more effective, accessible, and sustainable through advanced diagnostics. Our vision is to lead globally in gastrointestinal health, a goal we’re actively achieving with trusted solutions used worldwide. GastroPanel®, our non-invasive triage test for stomach health, is transforming care by identifying patients who truly need gastroscopy and enabling safe treatment in primary care. It also screens for Helicobacter pylori and atrophic gastritis—key risk factors for gastric cancer. Looking ahead, Biohit remains committed to innovation, early detection, and better outcomes in partnership with healthcare professionals across the globe.